Close
GS1 Global Healthcare Conference 2026
LiGHT 2026

Medtronic launches Discyphor direct catheter system

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

WebMD Ignite Ruby Transforms Healthcare Marketing...

WebMD Ignite has announced the launch of WebMD Ignite...

Mayo Clinic Study Validates AI Tool...

Researchers at Mayo Clinic have found that an artificial...

MHRA Outlines New Agenda for AI...

The United Kingdom’s Medicines and Healthcare products Regulatory Agency...
Medtronic, Inc. announced the U.S. launch of the Discyphor Direct™ Catheter System, the second-generation catheter system used by physicians to obtain additional information to diagnose discogenic low back pain.

The Discyphor Direct Catheter System provides additional information to help identify which disc is causing a patient’s pain.  More than 100,000 patients annually undergo spinal surgery for discogenic low back pain in the United States1, but patient satisfaction from such surgeries is mixed.

Robert White, president of Kyphon and Interspinous Process Decompression Devices for the Spinal and Biologics at Medtronic said, With the Discyphor Direct Catheter System, we are empowering physicians to  independently assess discs to determine the source of a patient’s back pain while delivering many enhancements over our first-generation product. Both patients and physicians will benefit from this new system because of its improved ease of use and a needle that is designed with an atraumatic or blunt tip.

With the Discyphor Direct Catheter System, physicians use Medtronic’s innovative Functional Anaesthetic Discography™ (F.A.D. ™) Procedure that identifies a patient’s discogenic pain by anesthetizing each suspect disc individually.  This procedure differs from typical means of diagnosis such as imaging studies or provocative discography, which generates pain in an attempt to locate the suspected disc.  The F.A.D. Procedure was introduced two years ago and has been used on more than 3,000 patients.

Never miss a healthcare headline

Healthcare moves fast – stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Related stories

Mayo Clinic Study Validates AI Tool DEXI for Skin Lesion Assessment

Researchers at Mayo Clinic have found that an artificial...

MHRA Outlines New Agenda for AI Medical Devices at AdvaMed

The United Kingdom’s Medicines and Healthcare products Regulatory Agency...

UK Confirms Indefinite Use of CE Marked Medical Devices

The United Kingdom government has officially confirmed the indefinite...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »